ADC THERAPEUTICS
Live / Registered — Registered (as of 16 Apr 2024)
What this means for you
Registered since 16 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90980910
- Registration number
- 7360943
- Mark type
- Stylized text
- Filed
- 05 Nov 2020
- Published for opposition
- 14 Jun 2022
- Registered
- 16 Apr 2024
- Attorney of record
- Tracy-Gene G. Durkin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for use in the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, pharmaceutical antibodies; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for the treatment of oncological diseases, disorders, and conditions; biological preparations for the treatment of oncological diseases, disorders, and conditions
Owner
- ADC Therapeutics SA, Epalinges, CH
- ADC Therapeutics SA, Epalinges, CH
- ADC Therapeutics SA, Epalinges, CH
Prior registrations
Prosecution history
- 25 Sept 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 16 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 Mar 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Mar 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Feb 2024 — USE AMENDMENT FILED
- 08 Mar 2024 — DIVISIONAL PROCESSING COMPLETE
- 26 Feb 2024 — DIVISIONAL REQUEST RECEIVED
- 27 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Feb 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 08 Feb 2024 — TEAS STATEMENT OF USE RECEIVED
- 11 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Aug 2023 — SOU EXTENSION 2 GRANTED
- 09 Aug 2023 — SOU EXTENSION 2 FILED